The Invesco Biotechnology & Genome ETF (PBE) made its debut on 06/23/2005, and is a smart beta exchange traded fund that provides broad exposure to the Health Care ETFs category of the market. What ...

Invesco Nasdaq Biotechnology ETF (NASDAQ:IBBQ – Get Free Report) saw a large drop in short interest during the month of February. As of February 28th, there was short interest totalling 3,900 shares, ...

VanEck Biotech ETF Trading Up 0.1 % BBH opened at $161.90 on Thursday. VanEck Biotech ETF has a twelve month low of $151.35 and a twelve month high of $183.64. The firm has a market capitalization ...

The SPDR S&P Biotech ETF (XBI) made its debut on 01/31/2006, and is a smart beta exchange traded fund that provides broad exposure to the Health Care ETFs category of the market. The ETF industry ...

the VanEck Biotech ETF (BBH) is a passively managed exchange traded fund launched on 12/20/2011. While an excellent vehicle for long term investors, passively managed ETFs are a popular choice ...

The First Trust NYSE Arca Biotechnology ETF (FBT) was launched on 06/19/2006, and is a smart beta exchange traded fund designed to offer broad exposure to the Health Care ETFs category of the market.

Biotech stocks are oversold. This near-term bottom might be the start of a long-term bull run. IBB and XBI offer different advantages. IBB can benefit from the flight to safety trade. XBI provides ...

"The reality is, for the biotech industry, while research is the ... and leaders across sectors and in the ETF space. For more expert insight and the latest market action, click here&nbsp ...

This chart compares three broad healthcare ETFs and three biotech ETFs. Data is sourced from ETFdb.com, a VettaFI company. The SPDR Portfolio S&P 500 ETF (SPLG) is used instead of SPY due to its ...

Income-based investors often devote a large part of their securities research time looking at bonds. dividend stocks, REITs, ...